Background
Head and neck cancers (HNCs) are one of the commonest cancers in low- and middle-income countries. There is a paucity of data on comorbid psychiatric problems associated with HNCs. The present study is aimed at reporting the pattern of psychiatric caseness in HNC patients who were referred to specialist psycho-oncology service and also investigate the predictors of psychiatric caseness in oral cancer patients.
Methods
Case records of all patients with HNC referred to an integrated psycho-oncology service over 7 years (October 2011–December 2018) from a cancer hospital were analysed. All patients were assessed by a trained consultant psychiatrist and ICD-10 diagnoses were ascertained based on a clinical interview with the patients and family members. Associations of psychiatric caseness for consecutive oral cancer patients assessed by the psycho-oncology services over 2 years (January 2017–December 2018) were calculated by using univariate and multivariate statistical methods. Simple descriptive statistics of the referred patients were conducted, followed by logistic regression to find the associations of psychiatric caseness in oral cancer patients.
Results
The psycho-oncology service assessed 771 HNC patients over 7 years. The commonest referrals were patients with oral cancer (75%, 558/771). For the years 2017–2018, 179 consecutive oral cancer patients were evaluated by the psycho-oncology service. Multivariate logistic regression analysis showed that being a woman (OR = 2.33; 95% CI = 1.02–5.32;
p
= 0.04); having worries about having pain in the post-operative period (OR = 2.55; 95% CI = 1.2–5.38;
p
= 0.01); worries about implications of the cancer and its treatment on the family (OR = 3.5; 95% CI = 1.19–10.57;
p
= 0.02); and longer duration of hospital stay period (OR = 1.08; 95% CI = 1.003–1.16;
p
= 0.04) were independently associated with psychiatric caseness even after controlling for confounders.
Discussion
Specialist psycho-oncology services are important in the management of oral cancer patients and in addressing the mental health needs of this very vulnerable group of patients. A combination of psychoeducation, pragmatic psychological interventions and medications were used to treat these patients.
Objective
Advanced stage at diagnosis and delayed presentation are common in ovarian cancer (OC). The objective of the current study was to explore the association of adult attachment pattern with delays in accessing specialist oncology care in patients with OC.
Methods
A cross-sectional structured interview study of patients with OC presenting to an Indian cancer center was undertaken. Consenting patients completed Experiences of Close Relationships–Relationship Style questionnaire (ECR-RS) and Medical Outcome Survey–Social Support Survey (MOS–SSS). Multivariate linear regression with “time to presentation to cancer specialist” as the dependent variable was undertaken.
Results
In all, 132 of 155 (85%) patients with OC who were invited were interviewed. An increased ECR-RS attachment anxiety score (
P
= .01) and being part of a multigenerational extended household (
P
= .04) were both independently associated with delay in presentation to a cancer specialist. There was no association between delay in presentation and social support.
Conclusions
Among patients with OC, adult attachment may contribute to delays in presentation. It may be important for the cancer symptom awareness efforts in primary care to include educating physicians on recognizing and interacting with patients with insecure attachment styles. The association of delays in presentation for women with OC living in multigenerational extended households needs more indepth exploration.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.